Reproducibility crisis: Blame it on the antibodies
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These serum cTnI enrichment results illustrate the major benefits of functionalized NPs compared to current antibody-based approaches: (1) NPs are capable of reproducibly and effectively enriching cTnI (Supplementary Fig. 23) across all tested serum samples without the use of antibody, thus overcoming the intrinsic antibody-related limitations (vide supra)14,15,51–53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, these NPs can serve as replacements to conventional immuno-based techniques to overcome the antibody-related limitations in cTnI immunoassays and potentially address the current reproducibility crisis caused by antibodies in general14–16,51,53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Yet a recent survey found that 70% of scientists have tried and failed to reproduce results from a published experiment.1”
From Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future Opportunities (2019) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“However, antibodies possess many inherent limitations: batch-to-batch variation, high cost of production, poor chemical stability, and lack of proteoform-specific epitope recognition that collectively contribute to reproducibility issues [62–64].”
From Top-down proteomics: challenges, innovations, and applications in basic and clinical research (2020) · cites this paper as [63]
In the citing paper
“However, antibody-based platforms suffer from significant limitations including the batch-to-batch variability, high cost of the antibody production, and relatively low chemical stability14,15.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
Berglund, L., Björling, E., Oksvold, P., Fagerberg, L., Asplund, A., Al-Khalili Szigyarto, C., Persson, A., Ottosson, J., Wernérus, H., Nilsson, P., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800013-mcp200 · Cited by 672
Reproducibility: Standardize antibodies used in research
Bradbury, A., & Plückthun, A. (2015) · Nature · doi:10.1038/518027a · Cited by 647
Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E., Baquero, M. T., Hanna, J. A., Anagnostou, V. K., & Rimm, D. L. (2010) · BioTechniques · doi:10.2144/000113382 · Cited by 589
An assessment of histone-modification antibody quality
Egelhofer, T. A., Minoda, A., Klugman, S., Lee, K., Kolasinska-Zwierz, P., Alekseyenko, A. A., Cheung, M.-S., Day, D. S., Gadel, S., Gorchakov, A. A., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1972 · Cited by 428
How reliable are G-protein-coupled receptor antibodies?
Michel, M. C., Wieland, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0395-y · Cited by 306
Prassas, I., & Diamandis, E. P. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-1078 · Cited by 31
Cited by
Items 301–400 of 816
A Laboratory Critical Incident and Error Reporting System for Experimental Biomedicine
Dirnagl, U., Przesdzing, I., Kurreck, C., & Major, S. (2016) · PLoS Biology · doi:10.1371/journal.pbio.2000705 · Cited by 23
Reproducibility Issues: Avoiding Pitfalls in Animal Inflammation Models
Laman, J. D., Kooistra, S. M., & Clausen, B. E. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6786-5_1 · Cited by 24
Evaluating Commercially Available Antibodies for Rat α7 Nicotinic Acetylcholine Receptors
Garg, B. K., & Loring, R. H. (2017) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155417725304 · Cited by 23
Construction of Synthetic Antibody Phage-Display Libraries
Nilvebrant, J., & Sidhu, S. S. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7447-4_3 · Cited by 23
Hober, A., Edfors, F., Ryaboshapkina, M., Malmqvist, J., Rosengren, L., Percy, A. J., Lind, L., Forsström, B., Uhlén, M., Oscarsson, J., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001765 · Cited by 26
“However, antibodies pose analytical challenges related to their specificity, selectivity and lot-to-lot variability as well as long development time and incomplete availability (3, 4).”
Functional Molecular Interfaces for Impedance-Based Diagnostics
Kanyong, P., Patil, A. V., & Davis, J. J. (2020) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-061318-115600 · Cited by 24
Lindner, L., Cayrou, P., Rosahl, T. W., Zhou, H. H., Birling, M., Hérault, Y., & Pavlovic, G. (2021) · Methods · doi:10.1016/j.ymeth.2021.04.001 · Cited by 28
“However, immunoblotting techniques such as western blotting are not truly quantitative [9,10] and are strongly biased by the availability of specific antibodies [11].”
Bonifacino, J. S., Gershlick, D. C., & Dell’Angelica, E. C. (2016) · Current Protocols in Cell Biology · doi:10.1002/cpcb.3 · Cited by 26
Selection and characterisation of Affimers specific for CEA recognition
Shamsuddin, S. H., Jayne, D. G., Tomlinson, D. C., McPherson, M. J., & Millner, P. A. (2021) · Scientific Reports · doi:10.1038/s41598-020-80354-6 · Cited by 22
The next “sweet” spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection
Xu, Y., Wang, Y., Höti, N., Clark, D. J., Chen, S., & Zhang, H. (2021) · Mass Spectrometry Reviews · doi:10.1002/mas.21748 · Cited by 26
Fodor, I., & Pirger, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.903575 · Cited by 22
Spatial omics techniques and data analysis for cancer immunotherapy applications
Zhang, Y., Lee, R. Y., Tan, C. W., Guo, X., Yim, W. W., Lim, J., Wee, F. Y. T., Wu, Y., Kharbanda, M., Lee, J.-Y. J., et al. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103111 · Cited by 24
Guan, P., Fang, J., Zhang, A., Gao, S. W., & Liu, Z. (2025) · ACS Nano · doi:10.1021/acsnano.4c13463 · Cited by 22
Đorđević, N., Dierks, C., Hantikainen, E. M., Farztdinov, V. M., Amari, F., Hernandes, V. V., Grandi, A. D., Domingues, F. S., Shomroni, O., Textoris‐Taube, K., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00856-0 · Cited by 23
A ChIP on the shoulder? Chromatin immunoprecipitation and validation strategies for ChIP antibodies
Wardle, F. C., & Tan, H. (2015) · F1000Research · doi:10.12688/f1000research.6719.1 · Cited by 26
Challenges and Reinterpretation of Antibody-Based Research on Phosphorylation of Tyr307 on PP2Ac
Mazhar, S., Léonard, D., Sosa, A., Schlatzer, D., Thomas, D., & Narla, G. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.012 · Cited by 22
“Insufficient validation of antibodies has been a major factor contributing to the 201Creproducibility crisis’’ in biomedical research (Baker, 2015).”
BackgroundXiong, Y., Li, M., Lu, W., Wang, D., Tang, M., Liu, Y., Na, B., Qin, H., & Qing, G. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03889 · Cited by 22
Frohner, I. E., Mudrak, I., Schüchner, S., Anrather, D., Hartl, M., Sontag, J., Sontag, E., Wadzinski, B. E., Preglej, T., Ellmeier, W., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.035 · Cited by 25
De novo design of high-affinity protein binders to bioactive helical peptides
Vázquez Torres, S., Leung, P. J. Y., Lutz, I. D., Venkatesh, P., Watson, J. L., Hink, F., Huynh, H.-H., Yeh, A. H.-W., Juergens, D., Bennett, N. R., et al. (2022) · doi:10.1101/2022.12.10.519862 · Cited by 22
Genetically Defined Strains in Drug Development and Toxicity Testing
Festing, M. F. W. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3661-8_1 · Cited by 25
Sun, Y. M., Ban, B., Bradbury, A. M., Ansari, G. A. S., & Blake, D. A. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b02334 · Cited by 21
Leung, I., Jarvik, N., & Sidhu, S. S. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.11.016 · Cited by 24
“First, the complex, heterotetrameric structure of conventional IgGs makes production technically challenging, which has been linked to batch-to-batch variations and problems with data reproducibility [11, 12].”
BackgroundIntact Transition Epitope Mapping - Thermodynamic Weak-force Order (ITEM - TWO)
Danquah, B. D., Yefremova, Y., Opuni, K. F. M., Röwer, C., Koy, C., & Glocker, M. O. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.103572 · Cited by 22
“It is imperative, therefore, to both structurally and functionally characterize antibodies in order to gain in-depth understanding of their functions; a task that although selfexplanatory is not easily fulfilled [15,16].”
BackgroundMa, Y., Li, X., Liu, J., Li, W., & Liu, Z. (2020) · ACS Sensors · doi:10.1021/acssensors.0c00359 · Cited by 21
Xu, S., He, H., & Liu, Z. (2021) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202100679 · Cited by 22
Analysis of Histone Antibody Specificity with Peptide Microarrays
Cornett, E. M., Dickson, B. M., & Rothbart, S. B. (2017) · Journal of Visualized Experiments · doi:10.3791/55912 · Cited by 24
Hendriks, J., Stojanovic, I., Schasfoort, R. B. M., Saris, D. B. F., & Karperien, M. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00260 · Cited by 23
Generation and diversification of recombinant monoclonal antibodies
DeLuca, K. F., Mick, J. E., Ide, A. H., Lima, W. C., Sherman, L., Schaller, K. L., Anderson, S. M., Zhao, N., Stasevich, T. J., Varma, D., et al. (2021) · eLife · doi:10.7554/elife.72093 · Cited by 21
Guo, Z., Zhao, J., He, H., & Liu, Z. (2022) · Chemistry - An Asian Journal · doi:10.1002/asia.202200844 · Cited by 20
Aptamer-functionalized liposomes for targeted cancer therapy
Moosavian, S. A., Kesharwani, P., Singh, V., & Sahebkar, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85881-6.00014-2 · Cited by 26
Ghanbarzadeh, M., Ghaffarinejad, A., & Shahdost-fard, F. (2024) · Talanta · doi:10.1016/j.talanta.2024.125927 · Cited by 20
Barford, K., Yap, C. C., Dwyer, N. D., & Winckler, B. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24168 · Cited by 23
“Recently, antibody specificity has become a concern in publications (Baker, 2015; Prassas & Diamandis, 2014), and we thus first validated the antibodies against NEEP21 and P19.”
BackgroundThe importance of behavioural bioassays in neuroscience
Brown, R. E., & Bolivar, S. (2017) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2017.05.022 · Cited by 25
“If the antibodies have batch-to-batch variability or bind to molecules other than the one that they are designed to detect (X), they lack reliability and validity (see Baker, 2015).”
BackgroundAntibody Screening by Microarray Technology—Direct Identification of Selective High-Affinity Clones
Paul, M., & Weller, M. G. (2020) · Antibodies · doi:10.3390/antib9010001 · Cited by 21
Affimers as an alternative to antibodies for protein biomarker enrichment
Tans, R., van Rijswijck, D. M. H., Davidson, A., Hannam, R., Ricketts, B., Tack, C. J., Wessels, H. J. C. T., Gloerich, J., & van Gool, A. J. (2020) · Protein Expression and Purification · doi:10.1016/j.pep.2020.105677 · Cited by 22
Bioinformatics tools and data resources for assay development of fluid protein biomarkers
Waury, K., Willemse, E. A. J., Vanmechelen, E., Zetterberg, H., Teunissen, C. E., & Abeln, S. (2022) · Biomarker Research · doi:10.1186/s40364-022-00425-w · Cited by 23
“This leads to many commercial antibodies not performing adequately, and their unreliability has been recognized as one of the major contributor to the reproducibility crisis of research [39, 46, 152].”
Background5 years later: irisin detection still an issue
Cooke, A. B., Sandoval, Y.-H. G., & Daskalopoulou, S. S. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0572 · Cited by 20
Natividad, L. A., Buczynski, M. W., McClatchy, D. B., & Yates, J. R. (2018) · Proteomes · doi:10.3390/proteomes6040050 · Cited by 21
“However, confounds associated with commercial antibodies for western blot analysis, including issues with reliability (batch-dependent variations) and selectivity (cross-reactivity and antigen/epitope binding) [30], often render this technique as somewhat restricted to previously implicated targets with a limited capa…”
BackgroundSciuto, M. R., Warnken, U. H., Schnölzer, M., Valvo, C., Brunetto, L., Boe, A., Biffoni, M., Krammer, P. H., Maria, R. D., & Haas, T. L. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o116.065920 · Cited by 21
“We want to emphasize that the quality of the abs used for the experiments is of highest importance to avoid inefficient precipitation or abundant non-specific interactions that are due to poor affinities or cross-reactivity of many commercially available abs (40, 41).”
BackgroundGarrido, N., & Juliá, M. G. (2024) · Biology · doi:10.3390/biology13010030 · Cited by 19
The role of irisin in kidney diseases
Li, X., & Lindholm, B. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117756 · Cited by 25
Li, X., Wang, J., Yang, G., Fang, X., Zhao, L., Luo, Z., & Dong, Y. (2024) · Molecules · doi:10.3390/molecules29081776 · Cited by 19
“As chemically synthesized agents, aptamers are also produced more affordably and re-producibly than antibodies [24], and also have other multifarious advantages such as good specificity, long-term stability during storage, ease to produce, liable modification, and meritable flexibility in different…”
BackgroundKimura, Y., Saito, N., Hanada, K., Liu, J., Okabe, T., Kawashima, S. A., Yamatsugu, K., & Kanai, M. (2015) · ChemBioChem · doi:10.1002/cbic.201500448 · Cited by 19
Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality
Li, D., De, S., Song, S., Matta, B., & Barnes, B. J. (2016) · Scientific Reports · doi:10.1038/srep31002 · Cited by 23
Danbolt, N. C., Zhou, Y., Furness, D. N., & Holmseth, S. (2016) · Glia · doi:10.1002/glia.23027 · Cited by 21
“We therefore fully agree with those who argue that commercial antibody producers should test their antibodies more rigorously before selling them to scientists or pathologists who often lack the resources or expertise to evaluate acquired antibodies (Baker, 2015; Boenisch, 2006; Bohmer et al., 2014; Couchman, 2009; Ka…”
Castillo, D., & Cassola, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182447 · Cited by 19
Sharing and reusing cell image data
Zaritsky, A. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-10-0606 · Cited by 19
Shatunova, E. A., Korolev, M. A., Omelchenko, V. O., Kurochkina, Y. D., Davydova, A., Venyaminova, A. G., & Vorobyeva, M. (2020) · Biomedicines · doi:10.3390/biomedicines8110527 · Cited by 23
Molecularly imprinted materials for biomedical sensing
Batista, A. D., Silva, W. R., & Mizaikoff, B. (2020) · Medical Devices & Sensors · doi:10.1002/mds3.10166 · Cited by 19
He, T., Zhang, Z., Zhang, X., Niu, H., Wang, S., Wang, Q., & Chen, L. (2025) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70000 · Cited by 18
“Furthermore, considering the higher antibodies levels in mice, it is plausible that the sensitivity of the immunoassay may vary among different species [40].”
Fourier, A., Dorey, A., Perret‐Liaudet, A., & Quadrio, I. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0607-2 · Cited by 19
“Miniaturization also provided a decrease of antibodies uptake, allowing a less frequent variation of antibodies batches, at the origin of a great variability [27].”
BackgroundRapid micro-immunohistochemistry
Lovchik, R. D., Taylor, D. P., & Kaigala, G. V. (2020) · Microsystems & Nanoengineering · doi:10.1038/s41378-020-00205-2 · Cited by 18
Chen, Y., Tang, R., Xiong, W., Zhang, F., Wang, N., Xie, B., Cao, J., Chen, Z.-K., & Ma, C. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04217-0 · Cited by 18
“Due to this characteristic, aptamers may bind target molecules with high specificity and affinity higher than that of corresponding antibodies [19, 20].”
BackgroundDevelopment of a peptide-based lateral flow assay for the detection of the cancer biomarker Mdm2
Gosselin, B., Retout, M., Jabin, I., & Bruylants, G. (2023) · Sensors & Diagnostics · doi:10.1039/d3sd00253e · Cited by 18
Functional Interface for Glycoprotein Sensing: Focusing on Biosensors
Qu, K., & Li, J. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c00607 · Cited by 18
The Power of Reagent Titration in Flow Cytometry
Bonilla, D. L., Paul, A., Gil‐Pulido, J., Park, L. M., & Jaimes, M. C. (2024) · Cells · doi:10.3390/cells13201677 · Cited by 23
“Many publications have detailed best practices for antibody titration as part of flow cytometry panel validation and evaluation [7,14–18].”
BackgroundAntibody Validation in Bioimaging Applications Based on Endogenous Expression of Tagged Proteins
Skogs, M., Stadler, C., Schutten, R., Hjelmare, M., Gnann, C., Björk, L., Poser, I., Hyman, A., Uhlén, M., & Lundberg, E. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00821 · Cited by 18
Lee, J., Appelmann, I., Miething, C., Shultz, T. O., Ruderman, D., Kim, D., Mallick, P., Lowe, S. W., & Wang, S. X. (2018) · Theranostics · doi:10.7150/thno.20706 · Cited by 18
“However, before measuring the titration curves, we tested the cross-reactivity between the 6-plex protein assays by using the method described previously [26], because there are concerns about the cross-reactivity of antibodies used in immunoassays [27].”
MethodGrzybowski, A. T., Shah, R. N., Richter, W. F., & Ruthenburg, A. J. (2019) · Nature Protocols · doi:10.1038/s41596-019-0218-7 · Cited by 20
Williams, E. C., Korchagina, E., Frame, T., Ryzhov, I. M., Bovin, N. V., & Henry, S. M. (2015) · Transfusion · doi:10.1111/trf.13384 · Cited by 18
Brier, S., Mignon, M. L., Jain, K., Lebrun, C., Peurois, F., Kellenberger, C., Floch, V. B., Mascarell, L., Nony, E., & Moingeon, P. E. (2017) · Allergy · doi:10.1111/all.13364 · Cited by 18
“The accuracy and precision of a quantitative ELISA depend upon the characteristics of the selected mAbs.(22,30) In this study, we used a combination of immunochromatography, pepscan, and mass spectrometric methods to delineate the epitopes recognized on Bet v 1 by 5B4 and 6H4 F IGURE 3 Mapping of the 5B4 and 6H4 epito…”
BackgroundMethodNguyen, J. V. L., Meziadi, A., Brunner, C., McKeague, M., Malic, L., & Tabrizian, M. (2025) · Advanced Science · doi:10.1002/advs.202516852 · Cited by 17
Applications of CRISPR-Cas Technologies to Proteomics
Dolgalev, G. V., & Poverennaya, E. V. (2021) · Genes · doi:10.3390/genes12111790 · Cited by 18
“However, not all proteins have both potent and specific antibodies available [103].”
BackgroundSpecific, sensitive and quantitative protein detection by in-gel fluorescence
Fuchs, A. C. D. (2023) · Nature Communications · doi:10.1038/s41467-023-38147-8 · Cited by 17
Guidelines on antibody use in physiology research
Brooks, H. L., Brás, L. E. D. C., Brunt, K. R., Sylvester, M. A., Parvatiyar, M. S., Sirish, P., Bansal, S. S., Sule, R. O., Eadie, A. L., Knepper, M. A., et al. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00347.2023 · Cited by 22
Klont, F., ten Hacken, N. H. T., Horvatovich, P. L., Bakker, S. J. L., & Bischoff, R. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01125 · Cited by 17
Zieba, A., Pontén, F., Uhlén, M., & Landegren, U. D. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.102 · Cited by 17
Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain
Quintino, L., Namislo, A., Davidsson, M., Breger, L. S., Kavanagh, P., Avallone, M., Wettergren, E. E., Isaksson, C., & Lundberg, C. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.08.008 · Cited by 18
“Although variation of pRPS6 is to be expected, as this protein is dependent on several signaling pathways and is a marker for neuronal activation,(22) in our experience, the variability observed was most likely due to antibody batch variation.(23) Despite this, our histology and results are in line with published lite…”
ResultMenoci: lightweight extensible web portal enhancing data management for biomedical research projects
Suhr, M., Lehmann, C. U., Bauer, C. R., Bender, T., Knopp, C. M., Freckmann, L., Hansen, B. Ö., Henke, C., Aschenbrandt, G., Kühlborn, L. K., et al. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03928-1 · Cited by 19
Deshpande, A., Vinayakamoorthy, R. M., Garg, B. K., Thummapudi, J. P., Oza, G., Adhikari, K., Agarwal, A., Dalvi, P., Iyer, S. K., Raman, S. T., et al. (2020) · Biomolecules · doi:10.3390/biom10030470 · Cited by 20
“[27] report the SH-EP1 cell line lacks RIC3, but is capable of αBGT binding when transfected with chrna7, and this binding does not change much when transfected with both chrna7 and ric3.”
Precise isolation and structural origin of an ultra-specific nanobody against chemical compound
Yang, H., Vasylieva, N., Wang, J., Li, Z., Duan, W., Chen, S., Wen, K., Meng, H., Yu, X., Shen, J., et al. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131958 · Cited by 17
Characterization of a sandwich ELISA for the quantification of all human periostin isoforms
Gadermaier, E., Tesarz, M., Suciu, A. A., Wallwitz, J., Berg, G. A., & Himmler, G. (2017) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22252 · Cited by 17
Thangsunan, P., Lal, N., Tiede, C., Moul, S. L., Robinson, J. I., Knowles, M. A., Stockley, P. G., Beales, P. A., Tomlinson, D. C., McPherson, M. J., et al. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.128829 · Cited by 17
Fundamentals of protein affinity chromatography: How to prepare and properly use an affinity matrix
Bílková, Z., Shabani, E., Moravek, O., Korecká, L., Slováková, M., & Jankovičová, B. (2025) · Journal of Chromatography A · doi:10.1016/j.chroma.2025.466061 · Cited by 17
Sensitive Protein Detection Using Site-Specifically Oligonucleotide-Conjugated Nanobodies
Al-Amin, R. A., Muthelo, P. M., Abdurakhmanov, E., Vincke, C., Amin, S. P., Muyldermans, S., Danielson, U. H., & Landegren, U. D. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00584 · Cited by 16
“Recombinant protein-binding reagents have the advantages over pAbs that they 31 can be produced in any desired amount, and they can be engineered for site-directed 32 conjugation of precisely one oligo per molecule, simplifying standardization (12-14).”
Biddle, M., Stylianou, P., Rekas, M., Wright, A. K. A., Sousa, J. V. R., Ruddy, D. A., Stefana, M. I., Kmiecik, K., Bandrowski, A. E., Kahn, R., et al. (2024) · mAbs · doi:10.1080/19420862.2024.2323706 · Cited by 18
Estrogen receptor beta expression and role in cancers
Monteiro, F. L., Stepanauskaitė, L., Archer, A., & Williams, C. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106526 · Cited by 16
“This was given priority because of the controversy of the field [13 – 18] and to adhere to guidelines for reproducible research [19,20].”
BackgroundOn the Necessity of Validating Antibodies in the Immunohistochemistry Literature
Gautron, L. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00046 · Cited by 16
“Then, academic journals published countless editorials, commentaries, and reviews on the problems with magic antibodies (Sim et al., 2004; Rhodes and Trimmer, 2006; Couchman, 2009; Kalyuzhny, 2009; Michel et al., 2009; Saper, 2009; Bordeaux et al., 2010; Hewitt et al., 2014; Baker, 2015; Bradbury and Plückthun, 2015;…”
BackgroundOpinion: Independent third-party entities as a model for validation of commercial antibodies
Laflamme, C., Edwards, A. M., Bandrowski, A. E., & McPherson, P. S. (2021) · New Biotechnology · doi:10.1016/j.nbt.2021.07.001 · Cited by 34
Fukuda, T., Nomura, M., Kato, Y., Tojo, H., Fujii, K., Nagao, T., Bando, Y., Fehniger, T. E., Marko‐Varga, G., Nakamura, H., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176219 · Cited by 16
Small-Molecule Patterning via Prefunctionalized Alkanethiols
Cao, H. H., Nakatsuka, N., Deshayes, S., Abendroth, J. M., Yang, H., Weiss, P. S., Kasko, A. M., & Andrews, A. M. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b00377 · Cited by 17
Baumer, Y., Gutierrez‐Huerta, C. A., Saxena, A., Dagur, P. K., Langerman, S. D., Tamura, K., Ceasar, J. N., Andrews, M. R., Mitchell, V. M., Collins, B. S., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02207-0 · Cited by 16
DNA aptamer-based rolling circle amplification product as a novel immunological adjuvant
Al-Ogaili, A. S., Liyanage, R., Lay, J. O., Jiang, T., Vuong, C. N., Agrawal, S., Kumar, T. K. S., Berghman, L. R., Hargis, B. M., & Kwon, Y. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-79420-w · Cited by 15
Nanobody mediated dual-mode immunoassay for detection of peanut allergen Ara h 3
Yao, C.-X., Hu, Y., Liu, Q., Liu, J., Ji, X., Lv, H., & Wang, S. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.137679 · Cited by 15
Increasing the functional density of threose nucleic acid
Majumdar, B., Sarma, D., Yu, Y., Lozoya‐Colinas, A., & Chaput, J. C. (2023) · RSC Chemical Biology · doi:10.1039/d3cb00159h · Cited by 16
“47 Aptamers, nucleic acid sequences that fold into shapes with target binding affinity, offer a possible alternative to antibodies.”
BackgroundCan antibodies be “vegan”? A guide through the maze of today’s antibody generation methods
Dübel, S. (2024) · mAbs · doi:10.1080/19420862.2024.2343499 · Cited by 15
“But why are research products that obviously are “littering the field with false findings” 34 still so popular?”
Nanobody-Based Immunoassays for the Detection of Food Hazards—A Review
Li, W., Xu, Z., He, Q., Pan, J., Zhang, Y., El-Sheikh, E.-S. A., Hammock, B. D., & Li, D. (2025) · Biosensors · doi:10.3390/bios15030183 · Cited by 15
“Additionally, the reproducibility crisis concerning antibodies has emerged as a widespread challenge in both academia and industry, and was extensively discussed in a series of articles in Nature in 2015 [105].”
Galindo, G., Maejima, D., DeRoo, J., Burlingham, S. R., Fixen, G. M., Morisaki, T., Febvre, H. P., Hasbrook, R., Zhao, N., Ghosh, S., et al. (2026) · Science Advances · doi:10.1126/sciadv.adx8352 · Cited by 21
“This is ideal because the number of publicly available antibody sequences is rapidly growing, as researchers prioritize preserving these sequences to address the antibody crisis caused by variability in commercial antibody batches ( 84 , 85 ).”
Multiplex Assay for Quantification of Acute Phase Proteins and Immunoglobulin A in Dried Blood Spots
Vidová, V., Stuchlíková, E., Vrbová, M., Almáši, M., Klánová, J., Thon, V., & Spáčil, Z. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00657 · Cited by 18
Jiang, F., Li, K., Archer, M., Mehta, M., Jamieson, E. L., CHARLES, A. K., Dickinson, J. E., Matsumoto, M., & Morahan, G. (2017) · Stem Cells · doi:10.1002/stem.2567 · Cited by 17
Image‐Based Cell Profiling Enables Quantitative Tissue Microscopy in Gastroenterology
Wills, J. W., Robertson, J., Summers, H. D., Miniter, M., Barnes, C. M., Hewitt, R. E., Keita, Å. V., Söderholm, J. D., Rees, P. C. T., & Powell, J. J. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24042 · Cited by 16
“In combination, the presented approaches take the field of gastroenterology far beyond the representative image, and should now help to combat some of the data reproducibility issues that are associated with antibody technologies and over-reliance on qualitative tissue microscopy (36,37).”
BackgroundThe Story of an Experiment: A Provenance-based Semantic Approach towards Research Reproducibility
Samuel, S., Groeneveld, K., Taubert, F., Walther, D., Kache, T., Langenstück, T., König‐Ries, B., Bücker, H. M., & Biskup, C. U. (2018) · Document Server@UHasselt (UHasselt) · doi:10.6084/m9.figshare.7345865 · Cited by 14
The African Female Breast Cancer Epidemiology Study Protocol
Ezeome, E., Yawe, K.-D. T., Ayandipo, O. O., Badejo, O., Adebamowo, S. N., Achusi, I. B., Fowotade, A., Ogun, G. O., & Adebamowo, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.856182 · Cited by 16
“Primary Antibody, Her2/Neu (SP3) Rabbit Monoclonal Antibody, and the BondTM Ready-to-Use Primary Antibody for Progesterone Receptor (16)] as the Department of Pathology, University of Maryland School of Medicine (93).”
MethodInfluentialAdvances in mass spectrometry-enabled multiomics at single-cell resolution
Kumar, R., Zemaitis, K. J., Fulcher, J. M., & Paša‐Tolić, L. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103096 · Cited by 17
Armero, L., Plou, J., Valera, P. S., Serna, S., García, I., & Liz‐Marzán, L. M. (2024) · ACS Sensors · doi:10.1021/acssensors.4c01252 · Cited by 15
“7,8 Therefore, alternative diagnostic tools have been developed, such as electrochemical impedance or quartz-crystal micro-balance with dissipation (QCM-D).”
The path to VICTORy – a beginner's guide to success using commercial research antibodies
Goodman, S. L. (2018) · Journal of Cell Science · doi:10.1242/jcs.216416 · Cited by 14
“And if that is clear, the next batch may differ, if it is even available (Baker, 2015a,b; Goodman, 2018)!”
BackgroundInfluentialChromatin Immunoprecipitation (ChIP) to Study DNA–Protein Interactions
Small, E. C., Maryanski, D. N., Rodriguez, K. L., Harvey, K. J., Keogh, M., & Johnstone, A. L. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1186-9_20 · Cited by 14
Maurin, C., Hé, Z., Mentek, M., Verhoeven, P. O., Pillet, S., Bourlet, T., Rogues, F., Pugniet, J. L., Peyragrosse, T., Barallon, M., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003922 · Cited by 14
“To validate high-quality and reproducible immunolabeling of the targets under study [24], several commercial antibodies targeting the same proteins were screened on noninfected VERO E6 cells, known to express SARS-CoV-2 receptors and activators [25], and infected VERO E6 cells for the screening of antibodies directed…”
BackgroundGarvin, A. J., Lanz, A. J., & Morris, J. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-25665-6 · Cited by 15
“Poor antibody characterization is a contributor to the reproducibility crisis in research 30,31 .”
Partridge, E. C., Watkins, T. A., & Mendenhall, E. M. (2016) · BioEssays · doi:10.1002/bies.201600028 · Cited by 15
“Unreliable repeatability of results has been reported [54, 55].”
Background
Metadata
- Authors
- Baker, M.
- Corresponding author
- Baker, Monya
- Venue
- Nature
- Published
- 2015-05-19
- Volume
- 521
- Issue
- 7552
- Pages
- 274-276
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1592986776
- Cited by
- 830
- References
- 7
- Citations by year
- 2026: 55 · 2025: 58 · 2024: 56 · 2023: 57 · 2022: 67 · 2021: 68 · 2020: 78 · 2019: 75 · 2018: 87 · 2017: 93 · 2016: 83 · 2015: 51
- Type
- other
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Keywords
- replication crisis, immunoglobulins, antibody validation, scientific rigor, research integrity
- MeSH terms
- Antibodies, Antibody Specificity, Cross Reactions, Humans, Indicators and Reagents, Membrane Proteins, Quality Control, Reagent Kits, Diagnostic, Reproducibility of Results, Artifacts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.